Ronan Kelly
罗南·凯利
MD, MBA
Director, Oncology and Hematology; Co-Director, Esophageal Cancer Program肿瘤与血液学主任；食管癌项目联合主任
👥Biography 个人简介
Dr. Ronan Kelly is a leading esophageal cancer specialist at Baylor Scott & White. He has conducted pivotal immunotherapy trials in esophageal cancer, contributing to defining pembrolizumab's role in the perioperative and advanced settings and advancing multidisciplinary care.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Perioperative Immunotherapy
Conducted key trials evaluating pembrolizumab in the neoadjuvant and adjuvant settings for resectable esophageal cancer, expanding curative-intent treatment options.
Multimodality Esophageal Cancer Care
Advanced multidisciplinary integration of immunotherapy with chemoradiation and surgery for esophageal cancer, improving pathologic complete response rates and long-term survival outcomes.
Representative Works 代表性著作
Pembrolizumab in resectable esophageal and gastroesophageal junction cancer: phase Ib KEYNOTE-975 study
Journal of Clinical Oncology (2023)
Established safety and preliminary efficacy of perioperative pembrolizumab in resectable esophageal cancer.
Cabozantinib in patients with advanced esophagogastric cancer: a phase 2 study
JAMA Oncology (2020)
Demonstrated cabozantinib activity in heavily pretreated esophagogastric cancer, identifying multi-kinase inhibition as a viable salvage strategy.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Zev Wainberg
UCLA Health / David Geffen School of Medicine
Cathy Eng
Vanderbilt-Ingram Cancer Center
Daniel Coit
Memorial Sloan Kettering Cancer Center
Johanna Bendell
Sarah Cannon Research Institute
关注 罗南·凯利 的研究动态
Follow Ronan Kelly's research updates
留下邮箱，当我们发布与 Ronan Kelly（Baylor Scott & White Health / Charles A. Sammons Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment